Next report date
Report period
Q1 2024
EPS estimate
−1.03EUR
Revenue estimate
396.67 MEUR
−3.20EUR
−398.86 MEUR
1.66 BEUR
125.76 M
About Alnylam Pharmaceuticals, Inc.
Sector
CEO
Yvonne L. Greenstreet
Headquarters
Cambridge
Website
Employees (FY)
2.1 K
Founded
2002
FIGI
BBG000Q4XD43
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where DUL is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange ALNYLAM PHARMACEUTICALS INC. stocks are traded under the ticker DUL.
ALNYLAM PHARMACEUTICALS INC. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
DUL earnings for the last quarter are 1.09 EUR per share, whereas the estimation was −1.37 EUR resulting in a 179.55% surprise. The estimated earnings for the next quarter are −1.07 EUR per share. See more details about ALNYLAM PHARMACEUTICALS INC. earnings.
ALNYLAM PHARMACEUTICALS INC. revenue for the last quarter amounts to 710.00 M EUR despite the estimated figure of 375.33 M EUR. In the next quarter revenue is expected to reach 395.85 M EUR.
Yes, you can track ALNYLAM PHARMACEUTICALS INC. financials in yearly and quarterly reports right on TradingView.
DUL net income for the last quarter is −124.91 M EUR, while the quarter before that showed 139.77 M EUR of net income which accounts for −189.37% change. Track more ALNYLAM PHARMACEUTICALS INC. financial stats to get the full picture.
No, DUL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DUL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALNYLAM PHARMACEUTICALS INC. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 2.10 K employees. See our rating of the largest employees — is ALNYLAM PHARMACEUTICALS INC. on this list?
We've gathered analysts' opinions on ALNYLAM PHARMACEUTICALS INC. future price: according to them, DUL price has a max estimate of 368.23 EUR and a min estimate of 126.78 EUR. Read a more detailed ALNYLAM PHARMACEUTICALS INC. forecast: see what analysts think of ALNYLAM PHARMACEUTICALS INC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALNYLAM PHARMACEUTICALS INC. EBITDA is −206.68 M EUR, and current EBITDA margin is −12.48%. See more stats in ALNYLAM PHARMACEUTICALS INC. financial statements.